Chargement en cours...
Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment
Lysosomal storage diseases are characterized by deficiencies in lysosomal enzymes, allowing accumulation of target substrate in cells and eventually causing cell death. Enzyme replacement therapy is the principal treatment for most of these diseases. However, these therapies are often complicated by...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2008
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3478093/ https://ncbi.nlm.nih.gov/pubmed/18688246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nbt.1484 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|